Publisher: Adis International
ISSN: 1173-5503
Source: PharmacoEconomics and Outcomes News, Vol.1, Iss.388, 2002-01, pp. : 6-6
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Enoxaparin sodium more effective, less costly than UFH
Inpharma, Vol. 1, Iss. 1363, 2002-01 ,pp. :
Graded activity no more effective, no less costly in OA
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 528, 2007-01 ,pp. :
Fondaparinux better than enoxaparin or UFH in ACS
Inpharma, Vol. 1, Iss. 1557, 2006-01 ,pp. :
Telithromycin less costly than clarithromycin for CAP
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 420, 2003-01 ,pp. :